EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

OC20 | UBIQUINOL DIACETATE AS A POTENTIAL NEUROPROTECTIVE AGENT: EVIDENCE FROM SH-SY5Y CELLS AND CAENORHABDITIS ELEGANS

European Journal of Histochemistry · 20.11.2026 · 70 (s2)

DOI: 10.4081/ejh.2026.4814 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Histochemistry, online erschienen am 20.11.2026. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Parkinson’s disease (PD) is characterized by the progressive loss of dopaminergic neurons and the accumulation of misfolded α-synuclein. Mitochondrial dysfunction and oxidative stress contribute to neurodegeneration. Coenzyme Q10 (CoQ10), an essential component of the mitochondrial electron transport chain and an antioxidant, has shown potential for neuroprotection, although its efficacy is limited by poor bioavailability and instability. Ubiquinol diacetate (CoQ10 Ac), an esterified CoQ10 derivative, may overcome these limitations by acting as a prodrug converted into its reduced antioxidant form by cellular esterases.

Aims

This study aimed to compare the antioxidant and neuroprotective effects of CoQ10 Ac and CoQ10 in SH-SY5Y cells and Caenorhabditis elegans models of PD.

Methods

SH-SY5Y cells were exposed to 6-hydroxydopamine (6-OHDA) to induce oxidative stress and neurotoxicity. Antioxidant activity, apoptotic markers, mitochondrial dynamics and integrity, and α-synuclein aggregation were evaluated. Neuroprotective and anti-aggregant effects were also investigated in C. elegans models expressing human α-synuclein.

Results

CoQ10 Ac showed greater antioxidant activity than CoQ10 in extracellular and intracellular compartments, particularly in membranes and the cytosol. It provided stronger protection against 6-OHDA-induced toxicity, more effectively reducing caspase-3 and PARP1 activation. Both compounds counteracted alterations in mitochondrial dynamics by reducing the DRP1/OPA1 ratio and increasing OPA1 levels. However, CoQ10 Ac was more effective in preserving mitochondrial integrity and mass. Both compounds significantly reduced 6-OHDA-induced α-synuclein aggregation. In C. elegans, CoQ10 Ac exhibited stronger neuroprotective and anti-aggregant effects than CoQ10, suggesting a potential advantage in bioavailability.

Conclusions

CoQ10 Ac demonstrated enhanced antioxidant and neuroprotective properties compared with CoQ10 in experimental PD models. Its effects on apoptosis, mitochondrial homeostasis and α-synuclein aggregation support further investigation of its potential as a neuroprotective prodrug candidate.

Zitieren

APA

(2026). OC20 | UBIQUINOL DIACETATE AS A POTENTIAL NEUROPROTECTIVE AGENT: EVIDENCE FROM SH-SY5Y CELLS AND CAENORHABDITIS ELEGANS. European Journal of Histochemistry, 70(s2). https://doi.org/10.4081/ejh.2026.4814

Vancouver

OC20 | UBIQUINOL DIACETATE AS A POTENTIAL NEUROPROTECTIVE AGENT: EVIDENCE FROM SH-SY5Y CELLS AND CAENORHABDITIS ELEGANS. European Journal of Histochemistry. 2026;70(s2). doi:10.4081/ejh.2026.4814

BibTeX
@article{euvimed2026,
  title = {OC20 | UBIQUINOL DIACETATE AS A POTENTIAL NEUROPROTECTIVE AGENT: EVIDENCE FROM SH-SY5Y CELLS AND CAENORHABDITIS ELEGANS},
  journal = {European Journal of Histochemistry},
  year = {2026},
  volume = {70},
  number = {s2},
  doi = {10.4081/ejh.2026.4814}
}
Kostenlos starten →